Jean‐Claude Gentet

3.7k total citations
62 papers, 2.2k citations indexed

About

Jean‐Claude Gentet is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Jean‐Claude Gentet has authored 62 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 15 papers in Neurology. Recurrent topics in Jean‐Claude Gentet's work include Sarcoma Diagnosis and Treatment (25 papers), Glioma Diagnosis and Treatment (13 papers) and Neuroblastoma Research and Treatments (13 papers). Jean‐Claude Gentet is often cited by papers focused on Sarcoma Diagnosis and Treatment (25 papers), Glioma Diagnosis and Treatment (13 papers) and Neuroblastoma Research and Treatments (13 papers). Jean‐Claude Gentet collaborates with scholars based in France, United States and United Kingdom. Jean‐Claude Gentet's co-authors include C Kalifa, François Doz, Didier Frappaz, Thierry Philip, Marie‐Cécile Le Deley, P. Chastagner, Hélène Pacquement, Olivier Hartmann, Pascal Chastagner and Françoise Méchinaud and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Jean‐Claude Gentet

62 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean‐Claude Gentet France	28	844	740	726	540	362	62	2.2k
Graziella Cefalo Italy	27	747 0.9×	487 0.7×	434 0.6×	411 0.8×	395 1.1×	76	1.9k
Jean B. Belasco United States	24	1.1k 1.3×	643 0.9×	511 0.7×	690 1.3×	535 1.5×	62	2.9k
Natia Esiashvili United States	27	965 1.1×	354 0.5×	382 0.5×	548 1.0×	534 1.5×	112	2.5k
Robert S. Lavey United States	25	498 0.6×	774 1.0×	520 0.7×	562 1.0×	724 2.0×	52	2.5k
M Brunat-Mentigny France	30	1.0k 1.2×	611 0.8×	474 0.7×	581 1.1×	498 1.4×	96	2.1k
Nathalie Gaspar France	27	867 1.0×	264 0.4×	624 0.9×	243 0.5×	583 1.6×	114	2.1k
Jean Claude Gentet France	24	474 0.6×	569 0.8×	418 0.6×	522 1.0×	301 0.8×	46	1.4k
Christine Devalck Belgium	22	394 0.5×	852 1.2×	316 0.4×	294 0.5×	336 0.9×	73	1.9k
Jean‐Michel Zucker France	32	1.5k 1.8×	575 0.8×	813 1.1×	971 1.8×	775 2.1×	77	3.7k
Pascal Chastagner France	34	513 0.6×	1.1k 1.5×	1.1k 1.5×	1.1k 2.1×	634 1.8×	161	3.5k

Countries citing papers authored by Jean‐Claude Gentet

Since Specialization

Citations

This map shows the geographic impact of Jean‐Claude Gentet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Claude Gentet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Claude Gentet more than expected).

Fields of papers citing papers by Jean‐Claude Gentet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Claude Gentet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Claude Gentet. The network helps show where Jean‐Claude Gentet may publish in the future.

Co-authorship network of co-authors of Jean‐Claude Gentet

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Claude Gentet. A scholar is included among the top collaborators of Jean‐Claude Gentet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Claude Gentet. Jean‐Claude Gentet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saultier, Paul, Zeinab Hamidou, Jean‐Claude Gentet, et al.. (2021). A Randomized Trial of Physical Activity in Children and Adolescents with Cancer. Cancers. 13(1). 121–121. 25 indexed citations

Marec‐Bérard, Perrine, Cécile Dalban, Nathalie Gaspar, et al.. (2019). A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma. European Journal of Cancer. 125. 58–68. 21 indexed citations

Verschuur, Arnauld, Philippe Dory‐Lautrec, Romain Truillet, et al.. (2018). Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial. Frontiers in Pharmacology. 9. 950–950. 20 indexed citations

Chastagner, Pascal, B Devictor, Birgit Geoerger, et al.. (2015). Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma. Cancer Chemotherapy and Pharmacology. 76(2). 425–432. 34 indexed citations

André, Nicolás, Jean‐Claude Gentet, Arnauld Verschuur, et al.. (2015). Pilot evaluation of physical and psychological effects of a physical trek programme including a dog sledding expedition in children and teenagers with cancer. ecancermedicalscience. 9. 558–558. 6 indexed citations

Marec‐Bérard, Perrine, Céline Ségura‐Ferlay, Marie‐Dominique Tabone, et al.. (2014). High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group. Sarcoma. 2014. 1–7. 7 indexed citations

Michel, Gérard, Dominique Valteau‐Couanet, Jean‐Claude Gentet, et al.. (2011). Weight‐based strategy of dose administration in children using intravenous busulfan: Clinical and pharmacokinetic results. Pediatric Blood & Cancer. 58(1). 90–97. 40 indexed citations

Rubie, Hervé, Birgit Geoerger, Didier Frappaz, et al.. (2010). Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours. European Journal of Cancer. 46(15). 2763–2770. 15 indexed citations

Geoerger, Birgit, Julia Chisholm, Marie‐Cécile Le Deley, et al.. (2010). Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study. European Journal of Cancer. 47(2). 230–238. 36 indexed citations

10.

Urien, Saı̈k, François Doz, Carole Giraud, et al.. (2010). Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect. Cancer Chemotherapy and Pharmacology. 67(3). 597–603. 6 indexed citations

11.

Faure‐Conter, Cécile, C. Carrié, V. Bernier, et al.. (2009). Intracranial Ependymomas in Children: Society of Pediatric Oncology Experience With Postoperative Hyperfractionated Local Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 74(5). 1536–1542. 25 indexed citations

12.

Salas, Sébastien, Pascal Jézéquel, L. Campion, et al.. (2009). Molecular characterization of the response to chemotherapy in conventional osteosarcomas: Predictive value of HSD17B10 and IFITM2. International Journal of Cancer. 125(4). 851–860. 35 indexed citations

13.

Salas, Sébastien, Catherine Bartoli, Jean‐Laurent Deville, et al.. (2007). Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 451(6). 999–1007. 35 indexed citations

14.

Claude, L., C. Carrié, N. Breteau, et al.. (2005). Recommandations pour la pratique clinique : Standards, Options 2004 pour la prise en charge des patients atteints d’ostéosarcome, Mise à jour 2004 du chapitre radiothérapie, Validation du rapport initial : mars 1995,1 ère validation de la mise à jour du chapitre radiothérapie : décembre 1998, 2 e validation de la mise à jour du chapitre radiothérapie : septembre 2004. Bulletin du Cancer. 92(10). 891–906. 4 indexed citations

15.

Claude, L., C. Carrié, N. Breteau, et al.. (2005). [Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Update 2004].. PubMed. 92(10). 891–906. 6 indexed citations

16.

Oberlin, Odile, Marie‐Cécile Le Deley, B. Bui, et al.. (2001). Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). British Journal of Cancer. 85(11). 1646–1654. 150 indexed citations

17.

Philip, Thierry, Jean‐Yves Blay, M Brunat-Mentigny, et al.. (1999). Standards, Options and Recommendations (SOR) for diagnosis, treatment and follow-up of osteosarcoma. Bulletin du Cancer. 86(2). 2 indexed citations

18.

Philip, Thierry, Jean‐Yves Blay, M Brunat-Mentigny, et al.. (1999). [Standards, options and recommendations (SOR) for diagnosis, treatment and follow-up of osteosarcoma. Groupe de travail SOR].. PubMed. 86(2). 159–76. 8 indexed citations

19.

Gentet, Jean‐Claude, Catherine Patte, E. Quintana, et al.. (1990). Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology.. Journal of Clinical Oncology. 8(4). 661–665. 39 indexed citations

20.

Gentet, Jean‐Claude, et al.. (1987). Continuous infusion of high-dose cisplatin in children: Pharmacokinetics of free and total platinum. European Journal of Cancer and Clinical Oncology. 23(11). 1649–1652. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact